Status:
ENROLLING_BY_INVITATION
Implementation Research on the LILAC Method to Educate Management of Elevated Lipoprotein(a).
Lead Sponsor:
Changi General Hospital
Conditions:
Lipoprotein(a)
Lipoprotein(a), Hyper-Lp(a)-Emia
Eligibility:
All Genders
16+ years
Brief Summary
The goal of this observational study is to assess the if short educational videos about #LILAC-for-Lpa are feasible and accepted in improving the confidence, testing, and management on Lipoprotein(a).
Detailed Description
The aims of this study are to (1) assess the feasibility of using these educational videos about LILAC-for-Lp(a) to help improve confidence, testing and the management of Lp(a), (2) assess the accepta...
Eligibility Criteria
Inclusion
- Participants include students, participants from institute of higher learning aged 16 and above.
- Participants aged 16 and above regardless of local or overseas, may also be from educational talks that Dr Loh is invited to speak at.
- Patients and members of the public aged 16 and above if they attend lipid awareness educational events.
- Participants aged 16 and above in patient support groups or patient advocacy networks.
Exclusion
- Participants aged below 16 years old.
Key Trial Info
Start Date :
September 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT07177612
Start Date
September 9 2025
End Date
December 1 2028
Last Update
September 22 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Online Portal, Australia
Perth, Australia
2
Online web portal
Kuala Lumpur, Malaysia
3
Changi General Hospital
Singapore, Singapore